Clinical trial

First Time in Human Study of Intravenous Interleukin-18 Antibody

NCT01035645

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-01-05

PhasePHASE1

Study timeline

Study start (actual)2010-01-05Date precision: day

Registry last updated2017-06-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Inflammatory Bowel Diseasesunresolved

Interventions

GSK1070806DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

CambridgeUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01035645 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.